By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Learn how our allogeneic, off-the-shelf VSTs are designed to treat or prevent devastating viral infections and diseases in patients with T cell deficiencies who have limited or no treatment options.
AlloVir is the global leader in developing VST immunotherapies
We develop highly innovative, allogeneic, off-the-shelf, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases.
Our Pipeline
Our allogeneic, off-the-shelf VST therapy candidates target 11 different devastating viruses as treatment or prevention.
Our approach involves the restoration of viral immunity through the adoptive transfer of VSTs, which have been prospectively generated from healthy, eligible donors. These cells are immediately available for patients at risk from the life-threatening consequences of viral diseases due to T cell deficiencies, including transplant recipients, immunocompromised cancer patients, the elderly, and the very young.
Virus-Specific T Cells Play a Central Role in Response to Viral Infection
Adaptive Cellular Immune Response in a Healthy Individual: Virus-specific T cell responses are vital components in cellular immunity against devastating viruses.
Viral Infection Activates and Expands Endogenous Helper (CD4+) and Cytotoxic (CD8+) T Cells
Expanded T cells Migrate to Site of Infection and Bind to Virus-infected cells
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?